Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Upgrade now.
Date Value
September 30, 2024 -1.566B
June 30, 2024 -1.274B
March 31, 2024 -989.00M
December 31, 2023 622.00M
September 30, 2023 -1.60B
June 30, 2023 -915.00M
March 31, 2023 -1.225B
December 31, 2022 1.662B
September 30, 2022 252.00M
June 30, 2022 304.00M
March 31, 2022 2.763B
December 31, 2021 3.31B
September 30, 2021 3.276B
June 30, 2021 4.063B
Date Value
March 31, 2021 2.971B
December 31, 2020 1.264B
September 30, 2020 893.00M
June 30, 2020 -24.00M
March 31, 2020 -106.00M
December 31, 2019 -99.05M
September 30, 2019 -107.09M
June 30, 2019 -108.58M
March 31, 2019 -144.27M
December 31, 2018 -91.02M
September 30, 2018 -80.21M
June 30, 2018 -48.25M
March 31, 2018 -111.38M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-1.60B
Minimum
Sep 2023
4.063B
Maximum
Jun 2021
679.10M
Average
278.00M
Median

Cash from Operations (Quarterly) Benchmarks

Eli Lilly and Co 3.712B
Merck & Co Inc 9.291B
Pfizer Inc 6.714B
Novavax Inc -144.81M
Biogen Inc 935.60M